Observational studyPharmacology research & perspectives2018

Pharmacokinetics, safety, and tolerability of the 2- and 3-direct-acting antiviral combination of AL-335, odalasvir, and simeprevir in healthy subjects.

Thomas N Kakuda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.